Document:

Exhibit 10.37

 

AMENDMENT TO EMPLOYMENT AGREEMENT

 

This Amendment (this
“Amendment”) dated as of the 12th day of February, 2021 amends the Employment Agreement, dated July
31, 2018 (the “Agreement”), by and between Adial Pharmaceuticals, Inc. (the “Company”), and
William B. Stilley, III (“Executive”). Capitalized terms used herein without definition shall have the meanings
assigned in the Agreement.  

 

WHEREAS, the
Company and the Executive desire to amend the Agreement as set forth below.

 

NOW THEREFORE,
for the mutual promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree to amend the Agreement as follows:

 

1. Term of Employment.
Section 1.16 of the Agreement is hereby deleted in its entirety and replaced with the following:

 

“1.16. “Term
of Employment” means the period commencing on the date hereof and ending on March 31, 2026.”

 

2. Annual Bonus.
The first sentence of Section 3.2 of the Agreement is hereby deleted in its entirety and replaced with the following:

 

“During the Term of Employment,
the Executive shall be eligible to earn an annual performance bonus based on the achievement of the performance goals established
by the Board or a committee thereof in its sole discretion, with an annual target bonus opportunity of forty percent (40%) of the
Base Salary and the potential to earn a higher bonus for above target performance, with the amount of any such bonus to be determined
in the sole discretion of the Board or a committee thereof, in any case, excluding the Executive (the “Annual Bonus”).”

 

3. No Other Amendments;
Confirmation. All other terms of the Agreement shall remain in full force and effect. The Agreement, as amended by this
Amendment, constitutes the entire agreement between the parties with respect to the subject matter thereof.

 

4. Counterparts.
This Amendment may be executed in one or more counterparts, each of which shall be deemed an original but both of which together
shall constitute one and the same instrument.

 

5. Choice of
Law. This Amendment shall be construed and interpreted in accordance with the internal laws of the State of Delaware without
regard to its conflict of laws principles.

 

[Signature page follows]

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Amendment as of the day and year first written above.

 

	 	Company:
	 	 	 
	 	ADIAL PHARMACEUTICALS, INC.
	 	 	 
	 	By:  	/s/ Joseph
    Truluck
	 	Name: 	Joseph Truluck
	 	Title:	 Chief Financial Officer
	 	 	 
	 	Executive:  
	 	 	 
	 	/s/ William B. Stilley, III
	 	WILLIAM B. STILLEY, IIIExhibit 10.38

 

AMENDMENT TO EMPLOYMENT AGREEMENT

 

This Amendment (this
“Amendment”) dated as of the 12th day of February, 2021 amends the Employment Agreement, dated July
31, 2018 (the “Agreement”), by and between Adial Pharmaceuticals, Inc. (the “Company”), and
Joseph Truluck (“Executive”). Capitalized terms used herein without definition shall have the meanings assigned
in the Agreement.  

 

WHEREAS, the
Company and the Executive desire to amend the Agreement as set forth below.

 

NOW THEREFORE,
for the mutual promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree to amend the Agreement as follows:

 

1. Term of Employment.
Section 1.16 of the Agreement is hereby deleted in its entirety and replaced with the following:

 

“1.16. “Term of
Employment” means the period commencing on the date hereof and ending on March 31, 2026.”

 

2. Reporting;
Outside Activities. The first sentence of Section 2.3 of the Agreement is hereby amended to read:

 

“During the Term of Employment,
the Executive shall report to the Chief Executive Officer, and the Executive shall diligently and conscientiously devote the Executive’s
business time, attention, energy, skill and best efforts as necessary, but in no event less than seventy-five percent (75%) of
his business time, to the business and affairs of the Company Group.”

 

3. Annual Salary.
The first sentence of Section 3.1 of the Agreement is hereby amended to read:

 

“During the Term of Employment,
the Executive shall initially receive an initial base salary per annum of Two-hundred sixty thousand ($260,000) Dollars, payable
in cash in accordance with the Company’s normal payroll practices as in effect from time to time.”

 

4. Annual Bonus.
The first sentence of Section 3.2 of the Agreement is hereby deleted in its entirety and replaced with the following:

 

“During the Term of Employment,
the Executive shall be eligible to earn an annual performance bonus based on the achievement of the performance goals established
by the Board or a committee thereof in its sole discretion, with an annual target bonus opportunity of twenty-five percent (25%)
of the Base Salary and the potential to earn a higher bonus for above target performance, with the amount of any such bonus to
be determined in the sole discretion of the Board or a committee thereof, in any case, excluding the Executive (the “Annual
Bonus”).”

 

5. No Other Amendments;
Confirmation. All other terms of the Agreement shall remain in full force and effect. The Agreement, as amended by this
Amendment, constitutes the entire agreement between the parties with respect to the subject matter thereof.

 

6. Counterparts.
This Amendment may be executed in one or more counterparts, each of which shall be deemed an original but both of which together
shall constitute one and the same instrument.

 

7. Choice of
Law. This Amendment shall be construed and interpreted in accordance with the internal laws of the State of Delaware without
regard to its conflict of laws principles.

 

[Signature page follows]

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Amendment as of the day and year first written above.

 

	 	Company:
	 	 	 
	 	ADIAL PHARMACEUTICALS, INC.
	 	 	 
	 	By:  	/s/ William B. Stilley,
    III
	 	Name: 	William B. Stilley, III
	 	Title:	Chief Executive Officer
	 	 	 
	 	Executive:  
	 	 	 
	 	/s/ Joseph Truluck
	 	JOSEPH TRULUCKExhibit 10.39

 

AMENDMENT TO EMPLOYMENT AGREEMENT

 

This Amendment (this
“Amendment”) dated as of the 17th day of March, 2021 amends the Employment Agreement, dated July
31, 2018, as amended (the “Agreement”), by and between Adial Pharmaceuticals, Inc. (the “Company”),
and William B. Stilley, III (“Executive”). Capitalized terms used herein without definition shall have the meanings
assigned in the Agreement.  

 

WHEREAS, Executive
was retained under the Employment Agreement by the Corporation to serve as its Chief Executive Officer; and

 

WHEREAS, in
recognition of the hard work and performance by Executive, the Corporation desires to amend the Employment Agreement.

 

NOW THEREFORE,
for the mutual promises contained herein and for other good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the parties hereto agree to amend the Employment Agreement as follows:

 

1. Amendment.
Section 3.1 of the Employment Agreement is hereby deleted in its entirety and replaced with the following:

 

“3.1Base
Salary. Effective February 12, 2021, the Executive shall receive a base salary per annum during the Term of Employment
of Four Hundred Ten Thousand Dollars ($410,000), payable in cash in accordance with the Company’s normal payroll practices
as in effect from time to time. During the Term of Employment, the Board may periodically review the Executive’s base salary
and the Board (excluding the Executive) may, in its sole discretion, set such base salary to an amount it determines to be appropriate,
provided, however, that any reduction will qualify as Good Reason under Section 1.11. The Executive’s base salary, as may
be in effect from time to time, is referred to herein as “Base Salary.”

 

2. No Other Amendments;
Confirmation. All other terms of the Agreement shall remain in full force and effect. The Agreement, as amended by this
Amendment, constitutes the entire agreement between the parties with respect to the subject matter thereof.

 

3. Counterparts.
This Amendment may be executed in one or more counterparts, each of which shall be deemed an original but both of which together
shall constitute one and the same instrument.

 

4. Choice of
Law. This Amendment shall be construed and interpreted in accordance with the internal laws of the State of Delaware without
regard to its conflict of laws principles.

 

[Signature page follows]

 

     

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Amendment as of the day and year first written above.

 

	 	Company:
	 	 
	 	ADIAL PHARMACEUTICALS, INC.
	 	 
	 	By:  	/s/ Joseph Truluck
	 	Name:	Joseph Truluck
	 	Title:	Chief Financial Officer
	 	 
	 	Executive: 
	 	 
	 	/s/ William B. Stilley, III
	 	WILLIAM B. STILLEY, IIIExhibit 10.9

 

SUBSCRIPTION AGREEMENT

 

THIS AGREEMENT
(this “Agreement”), is dated as of [•], 2021, by and between Alpha Partners Technology Merger Corp., a
Cayman Islands exempted corporation (the “Company”), and [•], a [•] (“Subscriber”).

 

WHEREAS, the
Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (a “Business Combination”);

 

WHEREAS, the
Company has filed with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-1
(the “Registration Statement”) for its initial public offering (“IPO”) of units (the “Public
Units”), at a price of $10.00 per Public Unit, each Public Unit comprised of one share of the Company’s Class A
common stock, par value $0.0001 per share (“Class A Common Stock”, and the shares of Class A Common Stock included
in the Public Units, the “Public Shares”), and one-third of one redeemable warrant, where each whole warrant
is initially exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share, subject to adjustment
(the “Warrants”, and the Warrants included in the Public Units, the “Public Warrants”);

 

WHEREAS, immediately
prior to the closing of the IPO (the “IPO Closing”), the Company and Alpha Partners Technology Merger Sponsor
LLC, a Delaware limited liability company (the “Sponsor”), have entered into, or intend to enter into, agreements
concurrently with this Agreement (collectively, with this Agreement, the “Subscription Agreements”), in substantially
the form of this Agreement, for the purchase of Founder Units and Private Placement Units set forth therein;

 

WHEREAS, Subscriber
(together with its affiliates, the “Subscriber Group”) has indicated an interest in purchasing, directly or
indirectly through its affiliated entities, 9.8% of the Public Units offered in the IPO (the “IPO Indication”),
which, together with the Private Placement Units purchased hereunder, would equal 9.9% of the total outstanding units of the Company
at the time of the IPO Closing (excluding any Public Units sold as a result of the exercise of the Underwriters’ Option (as
defined below));

 

WHEREAS, the
ultimate allocation of Public Units to the Subscriber Group may be equal to or less than the IPO Indication (such actual number
of Public Units purchased in the IPO by the Subscriber Group, the “IPO Allocation”);

 

WHEREAS, the
parties hereto desire that, upon the terms and subject to the conditions contained herein, the Company shall sell to Subscriber,
and Subscriber shall purchase, (i) certain units of the Company (the “Founder Units”), each such unit comprised
of one share of the Company’s Class B common stock, par value $0.0001 per share (the “Founder Shares”),
and one-third of one redeemable warrant, where each whole warrant is initially exercisable to purchase one share of Class A Common
Stock at an exercise price of $11.50 per share, subject to adjustment (the “Founder Warrants”), and (ii) certain
units of the Company with the same terms as the Founder Units (the “Private Placement Units” and, together with
the Founder Units, the “Securities”); and

 

WHEREAS, the
Company, the Sponsor and Subscriber intend for the purchase of Founder Units and Private Placement Units as set in the Subscription
Agreements to be made pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”);

 

WHEREAS, proceeds
from the IPO and the sale of the Private Placement Units in an aggregate amount equal to the aggregate gross proceeds from the
IPO will be deposited into a trust account for the benefit of the holders of the Public Shares (the “Trust Account”),
as described in the Registration Statement;

 

WHEREAS, following
the IPO Closing, the Company will seek to identify and consummate a Business Combination.

 

     

     

    

 

NOW, THEREFORE,
in consideration of the premises above, which are incorporated in this Agreement as if fully set forth below, and the mutual covenants
and other agreements contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the Company and Subscriber hereby agree as follows:

 

		1.	Closing; Conditions.

 

		(a)	Obligation. Upon execution, Subscriber’s obligation to purchase the Securities, and
the Company’s obligation to sell the Securities to Subscriber in a private placement transaction (the “Private Placement”),
shall be irrevocable, subject to the terms set forth in this Agreement.

 

		(b)	Closing. The closing of the purchase of the Private Placement Units (the “Units
Closing”) shall take place remotely via delivery of electronic documents, or such other place as determined by the Company,
contemporaneously with the closing of the IPO (the “Units Closing Date”). The closing of the purchase of the
Founder Units (the “Founder Units Closing”) shall take place remotely via delivery of electronic documents,
or such other place as determined by the Company, on the closing of the Business Combination (as defined below) (the “Founder
Units Closing Date”). As used herein, “Closing” means the Units Closing or the Founder Units Closing,
as applicable, and “Closing Date” means the Units Closing Date or the Founder Units Closing Date, as applicable.
If (i) the closing of the IPO has not occurred for any reason by May 31, 2021 or (ii) the Company is liquidated or dissolved prior
to the Founder Units Closing Date, then, unless Subscriber otherwise agrees in writing, this Agreement shall terminate and be of
no further force or effect.

 

		(c)	Closing Conditions. Subscriber’s obligation to purchase the Securities and the Company’s
obligation to sell the Securities to Subscriber is conditioned upon satisfaction of the following conditions precedent (any or
all of which may be waived by the Company or Subscriber upon written notice of such waiver to the other party):

 

(i)       On
the applicable Closing Date, no legal, administrative or regulatory action, suit or proceeding shall be pending which seeks to
restrain or prohibit the transactions contemplated by this Agreement.

 

(ii)       The
representations and warranties of the Company and Subscriber contained in this Agreement shall have been true and correct on the
date of this Agreement and shall be true and correct on the applicable Closing Date as if made on such Closing Date.

 

(iii)       The
Sponsor, its affiliates, limited partners of investment vehicles affiliated with the Sponsor and, with the prior consent of Subscriber
(not to be unreasonably withheld, conditioned or delayed) other parties designated by the Sponsor shall have purchased at least
eighty percent (80%) of the Private Placement Units offered by the Company in connection with the IPO which are not purchased by
the Subscriber Group.

 

		(d)	Subscription and Sale of the Securities. Subject to Section 1(f) hereof, (i) on the Units
Closing Date, Subscriber shall purchase from the Company, and the Company shall issue and sell to Subscriber, the number of Private
Placement Units indicated on the signature page hereof, in consideration for Subscriber’s purchase price for such Private
Placement Units indicated on the signature page hereof (the “Units Purchase Price”), on the terms and subject
to the conditions described herein, and (ii) on the Founder Units Closing Date, Subscriber shall purchase from the Company, and
the Company shall transfer and sell to Subscriber, the number of Founder Units indicated on the signature page hereof, in consideration
for Subscriber’s purchase price for such Founder Units indicated on the signature page hereof (the “Founder Units
Purchase Price” and, together with the Units Purchase Price, the “Purchase Price”), on the terms and
subject to the conditions described herein. The number of Securities and the amount of the Purchase Price indicated on the signature
page hereof may be increased or decreased pursuant to Section 1(f) hereof.

 

    2 

     

    

 

		(e)	Purchase of the Securities. The Company shall notify Subscriber in writing of the anticipated
date of the effectiveness of the Registration Statement (as defined below) (the “Effective Date”) at least two
(2) Business Days (as defined below) prior to the Effective Date, and Subscriber shall remit the Units Purchase Price to the Company’s
transfer agent (to be held in escrow pending the consummation of the IPO), by wire transfer of immediately available funds or other
means approved by the Company, on the date that is one (1) Business Day prior to the Effective Date, or such other date as the
Company and Subscriber may agree upon in writing. If the consummation of the IPO has not occurred for any reason by the date that
is seven (7) Business Days after the date on which Subscriber remitted the Units Purchase Price to the Company’s transfer
agent, then, unless Subscriber otherwise agrees in writing, the Company shall promptly cause its transfer agent to return the Units
Purchase Price to Subscriber without interest or deduction, and this Agreement shall terminate and thereafter have no force or
effect. The Company shall notify Subscriber in writing of the anticipated consummation date of the Business Combination at least
two (2) Business Days prior to such date, and the Company shall deliver the Founder Units to or as instructed by Subscriber against
payment of the Founder Units Purchase Price to accounts indicated by the Company by wire transfer of immediately available funds
or other means approved by the Company, on the Founder Units Closing Date, or such other date as the Company and Subscriber may
agree upon in writing. As used herein, “Business Day” means any day, other than a Saturday or Sunday, that is
neither a legal holiday nor a day on which banking institutions are generally authorized or required by law or regulation to close
in the City of New York, New York.

 

		(f)	Purchase of Additional Securities; Return of Unused Amount of Purchase Price. It is currently
contemplated that the IPO will raise $250,000,000 in gross proceeds (excluding exercise of the underwriter’s option to purchase
additional units in connection with the IPO (the “Underwriter’s Option”)). Subscriber agrees that, if
the size of the IPO is increased to $287,500,000 or more, pursuant to the exercise of the underwriter’s overallotment option
or otherwise, Subscriber shall receive an additional number of Founder Units as indicated on the signature page hereof. In the
case of such increase, the number of Private Placement Units, the Purchase Price for the Private Placement Units and the Purchase
Price for the Founder Units shall not be adjusted.

 

		2.	Representations and Warranties of Subscriber.

 

Subscriber
represents and warrants as follows:

 

		(a)	(i)      Subscriber is an “accredited investor” as defined by Rule 501 under the Securities
Act, as evidenced by the Accredited Investor Status Checklist (attached hereto as Exhibit A) and has such knowledge and
experience in financial and business matters that Subscriber is capable of evaluating the merits and risks of Subscriber’s
investment in the Securities, of making an informed investment decision with respect thereto, and has the ability and capacity
to protect Subscriber’s interests. Subscriber shall submit to the Company such further assurances of accredited status as
may reasonably be requested by the Company.

 

(ii)       Subscriber
understands that the Company is relying on the accuracy of these representations and warranties and understands the significance
of Subscriber’s representations and warranties to the Company that Subscriber is an accredited investor. By executing this
Agreement, Subscriber agrees to notify the Company of any material changes affecting Subscriber’s status prior to the Company’s
acceptance of the subscription.

 

		(b)	Subscriber understands that the Securities are not presently registered and the Company has no
obligation to register the Securities or assist Subscriber in obtaining an exemption from registration except as described in the
Registration Statement. Subscriber understands that the Private Placement Units and Founder Units will not be registered under
the Securities Act on the basis that the issuance of the Private Placement Units and Founder Units is exempt under either Section
4(a)(2) of the Securities Act or Regulation D promulgated under the Securities Act as a transaction by an issuer not involving
any public offering and that, in the view of the SEC, the statutory basis for the exemption claimed may not be present if any of
the representations and warranties of Subscriber contained in (a) through (d) of this Section 2 are untrue or, notwithstanding
Subscriber’s representations and warranties, Subscriber currently contemplates acquiring any of the Securities for resale.

 

    3 

     

    

 

		(c)	Subscriber is purchasing and acquiring the Securities for investment purposes and not with a view
to distribution or resale, nor with the intention of selling, transferring or otherwise disposing of all or any part thereof for
any particular price, or at any particular time, or upon the happening of any particular event or circumstance, except selling,
transferring, or disposing the Securities made in full compliance with all applicable provisions of the Securities Act, the rules
and regulations promulgated by the SEC thereunder, and applicable state securities laws; and Subscriber understands that an investment
in the Securities is not a liquid investment.

 

		(d)	Subscriber acknowledges that there exists no public market for the Securities, that no such public
market may develop in the future, the Securities, when sold or issued, will be “restricted securities” and as a result,
Subscriber acknowledges that the Securities may be required to be held indefinitely unless subsequently registered under the Securities
Act or unless an exemption from such registration is available. Subscriber is aware of the provisions of Rule 144 promulgated under
the Securities Act which permit resales of securities purchased in a private placement subject to certain limitations and to the
satisfaction of certain conditions provided for thereunder, including, among other things, the existence of a public market for
the securities, the availability of certain current public information about the company issuing the securities, the resale occurring
not less than six months after a party has purchased and paid for the security to be sold, the sale being effected through a “broker’s
transaction” or in transactions directly with a “market maker” and the number of securities being sold during
any three-month period not exceeding specified limitations. Subscriber further acknowledges that the Securities will be subject
to certain lock-up restrictions, as described in this Agreement, and may only be transferred pursuant to the terms of such lock-up.
Subscriber also acknowledges that Rule 144 is not available for the resale of securities initially issued by shell companies or
issuers that have been at any time previously a shell company and that Rule 144 will provide an exception to this prohibition only
if (i) the Company has then ceased to be a shell company; (ii) the Company is then subject to the reporting requirements of Section
13 or 15(d) of the Securities Exchange Act of 1934, as amended (“Exchange Act”); (iii) the Company has then
filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter
period that the Company was required to file such reports and materials), other than Form 8-K reports; and (iv) at least one year
has elapsed from the time that the Company filed current Form 10 type information with the SEC reflecting its status as an entity
that is not a shell company.

 

		(e)	Subscriber acknowledges that Subscriber has had the opportunity to ask questions of, and receive
answers from the Company or any authorized person acting on its behalf concerning the Company’s proposed business plan and
to obtain any additional information, to the extent possessed by the Company (or to the extent it could have been acquired by the
Company without unreasonable effort or expense) necessary to verify the accuracy of the information received by Subscriber. In
connection therewith, Subscriber acknowledges that Subscriber has had the opportunity to discuss the Company’s proposed business,
management and financial affairs with the Company’s management or any authorized person acting on its behalf. Subscriber
has received and reviewed all the information concerning the Securities and the Company’s business, management, financial
affairs, prospects and risks, both written and oral, that Subscriber desires. In determining whether to make this investment, Subscriber
has relied solely on (i) Subscriber’s own knowledge and understanding of the Company and its proposed business based upon
Subscriber’s own due diligence investigations and the information furnished pursuant to this paragraph, (ii) the information
described in subparagraph 2(g) below and (iii) the representations and warranties of the Company made to Subscriber in this Agreement.

 

		(f)	Subscriber has all requisite legal and other power and authority to execute and deliver this Agreement
and to carry out and perform Subscriber’s obligations under the terms of this Agreement. This Agreement constitutes a valid
and legally binding obligation of Subscriber, enforceable in accordance with its terms, subject to laws of general application
relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief
or other general principles of equity, whether such enforcement is considered in a proceeding in equity or law.

 

    4 

     

    

 

		(g)	Subscriber has carefully considered and has discussed with Subscriber’s legal, tax, accounting
and financial advisors, to the extent Subscriber has deemed necessary, the suitability of this investment and the transactions
contemplated by this Agreement for Subscriber’s particular federal, state, local and foreign tax and financial situation
and has independently determined that this investment and the transactions contemplated by this Agreement are a suitable investment
for Subscriber. Subscriber has relied solely on such advisors and not on any statements or representations of the Company or any
of its agents. Subscriber understands that Subscriber (and not the Company) shall be responsible for Subscriber’s own tax
liability that may arise as a result of this investment or the transactions contemplated by this Agreement.

 

		(h)	There are no actions, suits, proceedings or investigations pending against Subscriber or Subscriber’s
assets before any court or governmental agency (nor, to Subscriber’s knowledge, is there any threat thereof) which would
impair in any way Subscriber’s ability to enter into and fully perform Subscriber’s commitments and obligations under
this Agreement or the transactions contemplated hereby.

 

		(i)	The execution, delivery and performance of and compliance with this Agreement and the sale and
issuance of the Securities will not result in any violation of, or conflict with, or constitute a default under, any of Subscriber’s
articles of incorporation, by-laws, operating agreement, partnership agreement, or trust agreement, if applicable, or any agreement
to which Subscriber is a party or by which it is bound.

 

		(j)	Subscriber acknowledges that an investment in the Securities is speculative and involves a high
degree of risk and that Subscriber can bear the economic risk of the purchase of the Securities, including a total loss of its
investment. Subscriber acknowledges and understands and agrees that in the event the Company is unable to consummate a Business
Combination within a certain period of time following the closing of the IPO, then Subscriber may lose its entire investment.

 

		(k)	Subscriber understands that the officers and directors of the Company, and other similarly situated
individuals, may receive better terms than those being offered to Subscriber hereby, which have been disclosed to Subscriber.

 

		(l)	Subscriber recognizes that no federal, state or foreign agency has reviewed, recommended or endorsed
the purchase of the Securities or any facts or circumstances related thereto.

 

		(m)	Subscriber is aware that (i) the Company will have no operations and no commitments for any additional
capital that may be needed in the future and (ii) the Company will be a shell company. Subscriber has experience in evaluating
the risks of investing in early stage development companies and blank check companies.

 

		(n)	Subscriber represents that Subscriber is not purchasing or acquiring the Securities as a result
of or subsequent to any advertisement, article, notice or other communication published in any newspaper, magazine or similar media
or broadcast over the Internet, television or radio or presented at any seminar or meeting or any public announcement or filing
of or by the Company or any of its affiliates, agents or representatives.

 

		(o)	Subscriber has carefully read each of the terms and provisions of this Agreement.

 

		(p)	No representations or warranties have been made to Subscriber by the Company or any officer, employee,
agent, affiliate or subsidiary of the Company, other than the representations of the Company contained herein, and in purchasing
the Founder Units and subscribing for the Private Placement Units, Subscriber is not relying upon any representations other than
those contained in this Agreement. Subscriber has not been furnished with any oral representation or oral information in connection
with or in any way relating to the Private Placement or the proposed business or prospects of the Company.

 

    5 

     

    

 

		(q)	Subscriber represents and warrants it has not engaged any finder, broker, agent, financial advisor
or other intermediary, nor any purchaser representative or any broker-dealer acting as a broker, that is entitled to any compensation
in connection with the transactions contemplated by this Agreement.

 

		(r)	Subscriber acknowledges that if the Company does not complete an initial Business Combination within
the required time period, (i) the assets in the Company’s trust account, including any remaining proceeds of the sale of
the Private Placement Units, will be used to fund the redemption of its Public Shares and (ii) that there will be no liquidating
distributions from the Company’s trust account with respect to the Securities held by the Sponsor, and the Private Placement
Units and Founder Units will expire worthless.

 

		3.	Representations and Warranties of the Company.

 

The
Company represents and warrants as follows:

 

		(a)	Organization. The Company is duly organized and validly existing as a Cayman Islands exempted
corporation.

 

		(b)	Corporate Power. The Company has the power and authority to enter into, deliver and perform
this Agreement and the agreements to be entered into therewith.

 

		(c)	Authorization. All necessary action has been duly and validly taken by the Company to authorize
the execution, delivery and performance of this Agreement by the Company, and the issuance and sale of the Private Placement Units
to be sold by the Company pursuant to this Agreement. This Agreement has been duly and validly authorized, executed and delivered
by the Company and constitutes the legal, valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other
similar laws affecting the enforcement of creditors’ rights generally and by general equitable principles.

 

		(d)	Capitalization. The authorized share capital of the Company consists of, as of the date
hereof:

 

(i)       200,000,000
shares of Class A Common Stock, none of which are issued and outstanding;

 

(ii)      20,000,000
shares of Class B Common Stock, 7,187,500 of which are issued and outstanding. All of the outstanding shares of Class B Common
Stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and
state securities laws; and

 

(iii)     1,000,000
shares of preferred stock, none of which are issued and outstanding.

 

		(e)	Valid Issuance of Private Placement Units. The Private Placement Units and Founder Units,
when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement:

 

(i)       will
be free and clear of any preemptive or similar rights, taxes, security interests, liens, claims or other encumbrances, subject
only to restrictions upon transfer specified under this Agreement, that certain warrant agreement to be entered into by the Company
and Continental Stock Transfer & Trust Company, the Securities Act and any applicable state securities laws;

 

(ii)      will
be duly and validly issued, fully paid and non-assessable;

 

(iii)     will
not subject the holders thereof to personal liability by reason of being such holders; and

 

    6 

     

    

 

(iv)     assuming
the representations and warranties of Subscriber as set forth in Section 2 hereof are true and correct, will not result in a violation
of Section 5 under the Securities Act.

 

No “bad
actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification Event”)
is applicable to the Company or, to the Company’s knowledge, any Company Covered Person (as defined below), except for a
Disqualification Event as to which Rule 506(d)(2)(ii)-(iv) or (d)(3), is applicable. “Company Covered Person”
means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any
person listed in the first paragraph of Rule 506(d)(1).

 

		(f)	IPO. The offers and sales of securities in the IPO will be made pursuant to an effective
Registration Statement and otherwise in compliance with the Securities Act and the rules and regulations promulgated thereunder
and applicable state securities laws, rules and regulations.

 

		(g)	No General Solicitation. Neither the Company, nor to its knowledge, any person acting on
its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D
under the Securities Act) in connection with the offer or sale of the Private Placement Units or Founder Units.

 

		(h)	Governmental Consents and Filings. Assuming the accuracy of Subscriber’s representations
and warranties set forth in Section 2 and in the Accredited Investor Status Checklist attached hereto, no consent, approval, order
or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental
authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement,
except for filings pursuant to Regulation D of the Securities Act and applicable state securities laws, if any.

 

		(i)	Compliance with Other Instruments. The execution, delivery and performance of this Agreement
and the consummation of the transactions contemplated by this Agreement will not result in any violation or default (i) under any
provisions of the certificate of incorporation, bylaws or other governing documents of the Company, (ii) under any instrument,
judgment, order, writ or decree to which the Company is a party or by which it is bound, (iii) under any note, indenture or mortgage
to which the Company is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase order to which the
Company is a party or by which it is bound or (v) under any provision of federal or state statute, rule or regulation applicable
to the Company, in each case (other than clause (i)) which would have a material adverse effect on the Company or its ability to
consummate the transactions contemplated by this Agreement.

 

		(j)	Compliance with Laws. The Company has complied with all applicable statutes, rules, regulations,
orders and restrictions of any domestic or foreign government or any instrumentality or agency thereof having jurisdiction over
the conduct of their respective businesses or the ownership of their respective property except for any failure to comply with
any of the foregoing which could not reasonably be expected to have a material adverse effect.

 

		(k)	Operations. As of the date hereof, the Company has not conducted, and prior to the consummation
of the IPO the Company will not conduct any operations other than organizational activities and activities in connection with offerings
of the Securities.

 

		(l)	Foreign Corrupt Practices. Neither the Company, nor any director, officer, agent, employee
or other person acting on behalf of the Company has, in the course of its actions for, or on behalf of, the Company (i) used any
corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii)
made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii)
violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful
bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or
employee.

 

    7 

     

    

 

		(m)	Compliance with Anti-Money Laundering Laws. The operations of the Company are and have been
conducted at all times in compliance with applicable financial recordkeeping and reporting requirements and all other applicable
U.S. and non-U.S. anti-money laundering laws and regulations, including, but not limited to, those of the Currency and Foreign
Transactions Reporting Act of 1970, as amended, the USA Patriot Act of 2001 and the applicable money laundering statutes of all
applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued,
administered or enforced by any governmental agency (collectively, the “Anti-Money Laundering Laws”), and no
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

		(n)	Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before
or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company,
threatened against or affecting the Company or any of the Company’s officers or directors, whether of a civil or criminal
nature or otherwise, in their capacities as such.

 

		(o)	Non-Public Information. The Company represents and warrants that none of the information
conveyed to Subscriber in connection with the transactions contemplated by this Agreement will constitute material non-public information
of the Company upon the effectiveness of the Registration Statement.

 

		4.	[Intentionally omitted.]

 

		5.	Additional Agreements.

 

		(a)	No Short Sales. Subscriber hereby agrees that neither it, nor any person or entity acting
on its behalf, will engage in any Short Sales with respect to the Securities prior to the closing of the Business Combination.
For purposes of this Section 5(a), “Short Sales” shall include, without limitation, all “short sales” as
defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of direct and indirect stock pledges
(other than pledges in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options,
puts, calls, swaps and similar arrangements (including on a total return basis); provided, however, and for the avoidance
of doubt, that this Section 5(a) shall not prohibit Subscriber from effecting a Short Sale with securities that do not constitute
“Securities” under this Agreement.

 

		(b)	Lockup. Subscriber shall not transfer, assign or sell (i) any of the Founder Units
until the earliest of (A) one year following the closing of Business Combination and (B) subsequent to Business Combination,
(x) if the closing price of our Class A Common Stock equals or exceeds $12.00 per share (as adjusted for share sub-divisions,
share capitalizations, reorganizations, recapitalizations and other similar adjustments) for any 20 trading days within any 30-trading
day period commencing at least 150 days after the Business Combination, or (y) the date on which we complete a liquidation,
merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right
to exchange their ordinary shares for cash, securities or other property and (ii) any of its Private Placement Units and Class
A Common Stock issued upon conversion or exercise thereof until 30 days after the closing of the Business Combination. If at any
time, and for any reason, the Sponsor, or any other subscriber of Founder Units or Private Placement Units, receives terms more
favorable than the restrictions contained in this Section 5(b) (the “Lock-Up Restrictions”), then such terms
shall be equally applied to Subscriber’s Founder Units and/or Private Placement Units, as applicable; and the Lock-Up Restrictions
contained herein shall be amended, without any further required action of the parties hereto, to reflect the more favorable Lock-Up
Restrictions provided to the Sponsor or such other subscriber to such Founder Units and/or Private Placement Units.

 

		(c)	Registration Rights. The Company and Subscriber will enter into a registration rights agreement
on the Effective Date substantially in the form provided to Subscriber prior to the date hereof granting Subscriber customary registration
rights with respect to the Founder Units and Private Placement Units (and underlying Class A Common Stock) as described in the
Registration Statement.

 

    8 

     

    

 

		(d)	Reduction If Subscriber Exercises Redemption Rights or Sells Shares. Subscriber acknowledges
and agrees that it shall forfeit its right to receive a number of Founder Units determined in accordance with this Section 5(d)
if Subscriber holds less than a number of Class A Common Stock (excluding the Class A Common Stock included in the Private Placement
Units and excluding shares or units purchased by Subscriber in a private placement, if any, consummated by the Company after the
IPO in connection with the Company’s Business Combination) equal to the IPO Allocation (the “Required Number”)
on the Founder Units Closing Date (with the number of Public Shares still held by Subscriber on Founder Units Closing Date being
referred to herein as the “Subscriber’s Number”). Subscriber shall not forfeit any shares if the Subscriber’s
Number equals or exceeds the Required Number on the Founder Units Closing Date and the Company shall sell to Subscriber the number
of Founder Units indicated on the signature page hereof. However, if on the Founder Units Closing Date the Subscriber’s Number
is less than the Required Number, then the number of Founder Units sold to Subscriber will be equal to the number of Founder Units
indicated on the signature page hereof multiplied by a fraction, (i) the numerator of which is the Subscriber’s Number and
(ii) the denominator of which is the Required Number, at a nominal price per share as indicated on the signature page hereof. The
Company shall give Subscriber the lesser of (i) five (5) Business Days prior written notice or (ii) the number of days’ prior
written notice agreed to in connection with any financing obtained (debt or equity) in connection with the Business Combination,
of the Founder Units Closing Date.

 

		(e)	Changes in Connection with Business Combination. Subscriber
agrees that if, in connection with a Business Combination, the Sponsor decides (i) to forfeit, transfer to a third person,
exchange, subject to transfer, vesting or conditional forfeiture provisions, or amend the terms of all or any portion of the Founder
Units and/or the Private Placement Units (or the Sponsor’s membership interests representing an interest in any of the foregoing)
or (ii) to enter into any other arrangements with respect to the Founder Units and/or the Private Placement Units (or the
Sponsor’s membership interests representing an interest in any of the foregoing), to facilitate the consummation of such
Business Combination (each, a “Change in Investment”), such Change in Investment shall apply
pro rata to the Founder Units and/or Private Placement Units held by the Sponsor and
Subscriber based on the relative number of Founder Units and/or Private Placement Units to
be held by each on the Founder Units Closing Date; provided, that in each case Subscriber has been given notice at
least two (2) Business Days prior to any proposed Change in Investment. Subscriber agrees to take all steps and execute all such
agreements as may be necessary or reasonably requested by the Sponsor to effectuate such Change in Investment on the same terms
as applicable to the Sponsor.

 

		(f)	Automatic Conversion of Founder Shares. The Founder Shares acquired by Subscriber shall
automatically convert into Class A Common Stock of the Company on the Business Day following the closing of the Business Combination.
For the avoidance of doubt, Subscriber shall be prohibited form converting any acquired Founder Shares prior to the consummation
of the Business Combination.

 

		(g)	Right to Participate in Future Offerings; Favorable Terms. In the event the Company contemplates
an additional offering of securities in anticipation of the Business Combination, and if at the time of such additional offering
of securities the Subscriber’s Number is equal to or greater than the Required Number, the Company shall offer Subscriber
(together with any of its Permitted Transferees (as defined below)), the right to participate in such offering pro
rata in the same percentages of Public Units subscribed or purchased by Subscriber at the time of the IPO Closing. Additionally,
if the Company grants the Sponsor any rights with respect to the registration of any shares of equity securities of the Company
or any securities convertible or exercisable into shares of any equity securities of the Company that are more favorable to the
Sponsor than the rights of Subscriber set forth in this Subscription Agreement, then the Company shall grant to Subscriber the
same rights granted to the Sponsor. If the terms of the Public Units (including the ratio thereof) are amended after the date hereof,
the terms of the Founder Units shall be deemed to be amended, so that such terms are identical to the terms of the Public Units,
with no further action needed by the Company or Subscriber to effect such amendment. For purposes of this Agreement, “Permitted
Transferee” means the transferee of a sale, assignment, distribution, transfer or other disposition of Public Units,
Private Placement Units, Founder Units, any securities underlying any of the foregoing and/or any other securities of the Company
by Subscriber to an affiliate of the transferor; provided, however, that any Permitted Transferee must enter into
a written agreement agreeing to be bound by this Agreement.

 

    9 

     

    

 

		(h)	Material Non-Public Information. The Company shall not disclose to Subscriber any information
(including, without limitation, information that may be provided to the Company) that is material non-public information with respect
to any public company, including the Company. Should the Company determine that it is required to disclose such information under
the terms of this Agreement, or should it wish to do so in furtherance of the transactions contemplated hereby, the Company shall
consult with the Company’s General Counsel or Chief Compliance Officer (or their designees) regarding such potential disclosure.

 

		(i)	Independent Nature of Rights and Obligations. Nothing contained herein, and no action taken
by any party pursuant hereto, shall be deemed to constitute Subscriber and the Sponsor as, and the Sponsor acknowledges that Subscriber
and the Sponsor do not so constitute, a partnership, an association, a joint venture or any other kind of entity, or create a presumption
that Subscriber and the Sponsor are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by this Agreement or any matters, and the Sponsor acknowledges that Subscriber and the Sponsor are not acting in concert
or as a group, and the Sponsor shall not assert any such claim, with respect to such obligations or the transactions contemplated
by this Agreement.

 

		(j)	Waiver of Rights in Trust Account. Subscriber hereby agrees that it shall have no right
of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust Account,
and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have now or in the future, except
for redemption and liquidation rights, if any, Subscriber may have in respect of any Public Shares held by it. In the event Subscriber
has any Claim against the Company under this Agreement, Subscriber shall pursue such Claim solely against the Company and its assets
outside the Trust Account and not against the property or any monies in the Trust Account, except for redemption and liquidation
rights, if any, Subscriber may have in respect of any Public Shares held by it.

 

		(k)	Use of Subscriber’s Name. Neither the Company nor the Sponsor will, without the written
consent of Subscriber in each instance, use in advertising, publicity or otherwise the name of Subscriber or any of its affiliates,
or any equityholder, manager, director, officer or employee of Subscriber, nor any trade name, trademark, trade device, service
mark, symbol or any abbreviation, contraction or simulation thereof owned by Subscriber or its affiliates or any information relating
to the business or operations of Subscriber or its affiliates (including, for the avoidance of doubt, any investment vehicles,
funds or accounts managed thereby). Notwithstanding the foregoing, the Company may disclose Subscriber’s name and information
concerning Subscriber (A) to the extent required by law, regulation or regulatory request, including in the Registration Statement
or (B) to the Company’s lawyers, independent accountants and to other advisors and service providers who reasonably
require Subscriber’s information in connection with the provision of services to the Company, are advised of the confidential
nature of such information and are obligated to keep such information confidential. The Company and the Sponsor agree to provide
to Subscriber for Subscriber’s review any disclosure in any registration statement, proxy statement or other document in
advance of the submission, filing or disclosure of such document in connection with the transactions contemplated by this Agreement
with respect to Subscriber or any of its affiliates, and will not make any such submission, filing or disclosure without including
any revisions reasonably requested in writing by Subscriber or to the extent Subscriber has a good faith objection to such submission,
filing or disclosure.

 

		(l)	Beneficial Ownership Limitation. Notwithstanding anything to the contrary herein, none of
the rights of Subscriber provided for herein, shall result in Subscriber (together with any affiliates of Subscriber, and any persons
or entities acting as a group together with Subscriber or any affiliates of Subscriber) beneficially owning in excess of the Beneficial
Ownership Limitation (as defined below). Beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange
Act, and the rules and regulations promulgated thereunder. The “Beneficial Ownership Limitation” shall mean 9.9% of
the number of shares of the Public Units of the Company or any other class of securities that would be subject to Section 16 under
the Exchange Act or the rules and regulations promulgated thereunder.

 

		(m)	Prohibition on Certain Business Combinations. The Company shall not enter into a Business
Combination where the resultant company of such Business Combination would be classified as a U.S. Real Property Holding Corporation
under Section 897 of the Internal Revenue Code of 1986, as amended.

 

    10 

     

    

 

		6.	Miscellaneous.

 

		(a)	Notices. Any notice or other document required or permitted to be given or delivered to
the parties hereto shall be in writing and sent: (i) by registered or certified mail with return receipt requested (postage prepaid)
or (ii) by a recognized overnight delivery service (with charges prepaid).

 

If to the
Company, at:

Alpha Partners
Technology Merger Sponsor LLC

One Penn
Plaza, 36th Floor

New York,
NY 10119

Attention:Matthew
Krna

Sean
O’Brien

Email:matt@alphapartners.com

sean@alphapartners.com

 

With a copy
which shall not constitute notice to:

 

Davis Polk
& Wardwell LLP

450 Lexington
Avenue

New York,
NY 10017

Attention:
Derek Dostal

 Leonard
Kreynin

Email:derek.dostal@davispolk.com 

Leonard.kreynin@davispolk.com

 

If to Subscriber,
at its address set forth on the signature page to this Agreement, or such other address as Subscriber shall have specified to the
Company in writing.

 

		(b)	Entire Agreement; Amendments; Assignment. This Agreement, together with any other documents,
instruments and writings that are delivered pursuant hereto or referenced herein, represents the entire agreement between the parties
hereto with respect to the subject matter hereof and supersedes all prior understandings, agreements or representations by or among
the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof of the transactions contemplated
hereby. This Agreement may be terminated, modified, waived or amended only by a writing executed and delivered by both parties
hereto. No right or obligation of a party shall be assigned or otherwise transferred without prior notice to and the written consent
of the other party provided, that, Subscriber may assign or otherwise transfer any right or obligation hereunder to a Permitted
Transferee. Any assignment or transfer in violation of the foregoing shall be null and void.

 

		(c)	Counterparts/Execution. This Agreement may be executed in any number of counterparts and
by the different signatories hereto on separate counterparts, each of which, when so executed, shall be deemed an original, but
all such counterparts shall constitute but one and the same instrument. This Agreement may be executed by facsimile transmission,
PDF, electronic signature or other similar electronic means with the same force and effect as if such signature page were an original
thereof.

 

		(d)	Law Governing this Agreement. This Agreement, the entire relationship of the parties hereto,
and any litigation between the parties (whether grounded in contract, tort, statute, law or equity) shall be governed by, construed
in accordance with, and interpreted pursuant to the laws of the State of New York, without giving effect to its choice of law principles.

 

    11 

     

    

 

		(e)	Successors. All of the terms, agreements, covenants, representations, warranties, and conditions
of this Agreement are binding upon, and inure to the benefit of and are enforceable by, the parties hereto and their respective
successors. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or
their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement,
except as expressly provided in this Agreement.

 

		(f)	WAIVER OF JURY TRIAL. EACH PARTY HERETO (INCLUDING ITS AFFILIATES, AGENTS, OFFICERS, DIRECTORS
AND EMPLOYEES) HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY
IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY.

 

		(g)	Specific Enforcement; Consent to Jurisdiction. The Company and Subscriber acknowledge and
agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance
with their specific terms or were otherwise breached. It is accordingly agreed that the parties hereto shall be entitled to seek
an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement and to enforce specifically the terms
and provisions hereof, this being in addition to any other remedy to which any of them may be entitled by law or equity. The parties
hereby irrevocably and unconditionally (i) submit to the jurisdiction of the state courts of New York and the United States District
Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or based upon
this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except
in state courts of New York or the United States District Court for the Southern District of New York, and (iii) waive, and agree
not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject
personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that
the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper
or that this Agreement or the subject matter hereof may not be enforced in or by such court.

 

		(h)	Drafting. This Agreement shall not be construed for or against a party hereto based upon
authorship.

 

		(i)	Captions; Certain Definitions. The captions of the various sections and paragraphs of this
Agreement have been inserted only for the purposes of convenience; such captions are not a part of this Agreement and shall not
be deemed in any manner to modify, explain, enlarge or restrict any of the provisions of this Agreement. As used in this Agreement
the term “person” shall mean and include an individual, a partnership, a joint venture, a corporation, a limited
liability company, a trust, an unincorporated organization or any other legal entity and a government or any department or agency
thereof.

 

		(j)	Severability. In the event that any term or provision of this Agreement shall be finally
determined to be superseded, invalid, illegal or otherwise unenforceable pursuant to applicable law by an authority having jurisdiction
and venue, that determination shall not impair or otherwise affect the validity, legality or enforceability: (i) by or before that
authority of the remaining terms and provisions of this Agreement, which shall be enforced as if the unenforceable term or provision
were deleted, or (ii) by or before any other authority of any of the terms and provisions of this Agreement.

 

		(k)	Expenses. Each of the Company and Subscriber will bear its own costs and expenses incurred
in connection with the preparation, execution and performance of this Agreement and the consummation of the transactions contemplated
hereby, including all fees and expenses of agents, representatives, financial advisors, legal counsel and accountants The Company
shall be responsible for the fees of its transfer agent, stamp taxes and all of The Depository Trust Company’s fees associated
with the issuance of the Securities and the securities issuable upon conversion or exercise of the Securities.

 

    12 

     

    

 

		(l)	Confidentiality. Except as may be required by law, regulation or applicable stock exchange
listing requirements (but subject in any case to the provisions of Section 5(h) hereof), unless and until the transactions
contemplated hereby and the terms hereof are publicly announced or otherwise publicly disclosed by the Company, the parties hereto
shall keep confidential and shall not publicly disclose the existence or terms of this Agreement. Notwithstanding the foregoing,
Subscriber shall be permitted to disclose any information to its affiliates and its and their respective directors, officers, employees,
advisors, director or indirect owners, agents and representatives, in each case so long as such person or entity has been advised
of the confidentiality obligations hereunder; provided that Subscriber shall be liable for any breach of such confidentiality obligations
by any such person or entity.

 

		(m)	Survival of Representations and Warranties. All of the representations and warranties contained
herein shall survive the consummation of the transactions contemplated by this Agreement.

 

(Signature pages follow.)

 

    13 

     

    

 

IN WITNESS WHEREOF,
Subscriber has caused this Agreement to be executed as of the date indicated below.

 

	Number of Private Placement Units to be purchased at $10.00 per unit*	 	 	[•]	 
	Purchase price for Private Placement Units	 	 	$[•]	 
	Number of Founder Units to be sold pursuant to a $250,000,000 IPO*	 	 	[•]	 
	Additional Founder Units to be sold pursuant to a $287,500,000 or greater IPO	 	 	[•]	 
	Purchase Price for Founder Units	 	 	$[•]	 
	Purchase Price	 	 	$[•]	 
	*Subject to adjustment pursuant to Section 1(f) of this agreement	 	 	 	 

 

	 	SUBSCRIBER:
	 	 
	 	[•]
	 	 
	 	 	 	 
	 	By:	 
	 	 	Name:	 
	 	 	Title: 	 

 

 

Date: [•], 2021

 

Subscriber’s Address for Notices:

 

[•]

 

    14 

     

    

 

Acceptance and Agreement:

 

IN WITNESS WHEREOF,
the Company has caused this Agreement to be executed, and the foregoing subscription accepted and agreed to, as of the date indicated
below.

 

	 	COMPANY:
	 	 
	 	Alpha Partners
Technology Merger Corp.
	 	 
	 	 	 	 
	 	By:	 
	 	 	Name:	 
	 	 	Title: 	 

 

 

Date: [•], 2021

 

    15 

     

    

 

Exhibit A –
Accredited Investor Questionnaire

 

 

SUBSCRIBER TO COMPLETE

 

Accredited Investor
Status Checklist:

 

Please check one or
more of the following definitions of “accredited investor,” if any, which applies to you. If none of the following
applies to you, you may not qualify to take parting this offering.

 

	☐	A Bank as defined in Section 3(a)(2) of the Securities Act, or any savings association or institution as defined in Section 3(a)(5)(A) of the Securities Act.
	 	 
	☐	Any broker or dealer registered pursuant to Section 15 of the Exchange Act.
	 	 
	☐	An insurance company as defined in Section 2(13) of the Securities Act.
	 	 
	☐	Investment company registered under the Investment Company Act of 1940, as amended (the “Investment Company Act”) or a business development company as defined in Section 2(a)(48) of the Investment Company Act.
	 	 
	☐	Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958, as amended.
	 	 
	☐	Plan established and maintained by a state, or its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000.
	 	 
	☐	Any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, as amended, if the investment decision is made by a plan fiduciary, as defined in the Securities Act, which is either a bank, savings and loan association, insurance company, or registered investment advisor, or if the plan has assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are Accredited Investors.
	☐	A Private Business Development Company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940, as amended.
	 	 
	☐	An organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation, business trust, partnership, or limited liability company, or any other entity, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000.
	 	 

 

Accredited Investor
Questionnaire

 

     

     

    

 

	☐	
        A natural person whose
        individual net worth, or joint net worth with that person’s spouse, at the time of purchase exceeds $1,000,000.

         

        The
        term “net worth” means the excess of total assets over total liabilities (including personal and real property, but excluding the
        estimated fair market value of Subscriber’s primary home). For the purposes of calculating joint net worth with the person’s
        spouse or spousal equivalent, joint net worth can be the aggregate net worth of Subscriber and spouse or spousal equivalent; assets
        need not be held jointly to be included in the calculation. There is no requirement that securities be purchased jointly. A spousal
        equivalent means a cohabitant occupying a relationship generally equivalent to a spouse.

         

	☐	
        A natural person who
        had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s spouse
        or spousal equivalent in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income
        level in the current year.

         

        For purposes
hereof the term “income” is not limited to “adjusted gross income” as that term is defined for federal
income tax purposes, but rather includes certain items of income which are deducted in computing “adjusted gross income.”
For investors who are salaried employees, the gross salary of such investor, minus any significant expenses personally incurred
by such investor in connection with earning the salary, plus any income from any other source including unearned income, is a
fair measure of “income” for purposes hereof. For investors who are self-employed, “income” is generally
construed to mean total revenues received during the calendar year minus significant expenses incurred in connection with earning
such revenues.

	 	 
	☐	A trust, with assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Securities, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2) (ii) of Regulation D of the Securities Act.
	 	 
	☐	Any entity in which all of the equity owners are Accredited Investors.
	 	 
	☐	A director or officer of the Company.
	 	 
	☐	A natural person holding in good standing with one or more professional certifications or designations or other credentials from an accredited educational institution that the U.S. Securities Exchange Commission (“SEC”) has designated as qualifying an individual for accredited investor status;   The SEC has designated the General Securities Representative license (Series 7), the Private Securities Offering Representative license (Series 82) and the Licensed Investment Adviser Representative (Series 65) as the initial certifications that qualify for accredited investor status.  
	 	 
	☐	A natural person who is a “knowledgeable employee” as defined in Rule 3c-5(a)(4) under the Investment Company Act, of the issuer of the securities being offered or sold where the issuer would be an investment company, as defined in section 3 of the Investment Company Act, but for the exclusion provided by either section 3(c)(1) or section 3(c)(7) of the Investment Company Act;
	 	 
	☐	
        An investment adviser
        registered pursuant to section 203 of the Investment Advisers Act of 1940 (the “Investment Advisers Act”) or
        registered pursuant to the laws of a state, or an investment adviser relying on the exemption from registering with the SEC under
        the section 203(l) or (m) of the Investment Advisers Act;

         

	☐	
        A Rural Business Investment
        Company as defined in section 384A of the Consolidated Farm and Rural Development Act;

         

	☐	
        A “family office”
        as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act with assets under management in excess of $5,000,000 that
        is not formed for the specific purpose of acquiring the securities offered and whose prospective investment is directed by a person
        who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the merits
        and risks of the prospective investment;

         

	☐	A “family client” as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act, of a family office meeting the requirements set forth in the preceding row and whose prospective investment in the issuer is directed by a person from a family office that is capable of evaluating the merits and risks of the prospective investment;

 

Accredited Investor
Questionnaire

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]